Does CMS' Part B drug proposal usurp clinical judgment?

Modern Healthcare (complimentary online subscription): Medicare's plans to overhaul the way it reimburses doctors and hospitals for the more than $20 billion worth of outpatient drugs they administer each year has sharply divided the provider community. The fault lines roughly align with the stakes in the status quo. The five-year pilot is intended to test the effectiveness of strategies that remove the profit motive from using more expensive drugs over cheaper alternatives.

Read article

i360Gov Newsletters

The most significant government policy, business, and technology news and analysis delivered to your inbox.

Subscribe Now

Trending